plant medicine coalition

This Week in Psychedelics - 4.16.21

ThisWeekinPsychedelics.png

Cannabis

  • New Mexico Legalizes Adult-Use Cannabis (Forbes)

  • 69 Percent Of Americans Now Support Legalizing Marijuana—An All-Time High, Quinnipiac Poll Finds (Marijuana Moment)

  • Marijuana legalization has won (Vox)

  • Four More States Could Still Legalize Marijuana This Year After New Mexico, New York And Virginia (Marijuana Moment)

  • Nevada Lawmakers Approve Marijuana Bill To Allow On-Site Consumption Lounges (Marijuana Moment)

  • Alabama Medical Marijuana Legalization Bill That Already Passed The Senate Heads To House Floor (Marijuana Moment)

  • Women Paved the Way for Mexico’s Cannabis Legalization Movement, and Here’s How They Did It (MERRY JANE)

  • Limited Tennessee Medical Marijuana Bill Heads To Senate Floor (Marijuana Moment)

  • Sixth Minnesota House Committee Approves Marijuana Legalization Bill On Its Path To The Floor (Marijuana Moment)

  • Texas Lawmakers Approve Marijuana Decriminalization Bill In Committee (Marijuana Moment)

  • With Virginia moving forward, state Democratic leaders want NC to be next to legalize marijuana (Fox 8)

Magic Mushrooms

  • Psilocybin Therapy May Work as Well as Common Antidepressant (Scientific American)

  • Denver pursues further decriminalization of magic mushrooms (Axios)

  • Psychedelic Experience May Not Be Required For Psilocybin’s Antidepressant-Like Benefits (Neuroscience News)

  • Psilocybin Mushrooms Greatly Enhance Creative Thinking, New Clinical Study Confirms (MERRY JANE)

  • Silo Wellness Announces Intellectual Property Licensing Agreement of Psilocybin Nasal Spray in Colombia and Brasil (Psilocybin Alpha)

  • Wood Lover’s Paralysis: Psilocybin’s Rare Sickness (Truffle Report)

5-MeO-DMT

  • The Story Behind a 1984 Hallucinogenic Pamphlet From Denton Is Just as Trippy as Its Subject (Dallas Observer)

Mescaline

  • Keepers of the Matrix: A Beginner’s Guide to Understanding Sacred Cacti (DoubleBlind)

Peyote

  • Peyote Conservation Group Asks to Include Cultivation in California Decrim Bill (Truffle Report)

Synthetic Cannabinoids

Miscellaneous

  • Psychedelics In Groups? First Study Of Its Kind Shows Potential For Collective Settings (Forbes)

  • California Bill To Legalize Possession Of Psychedelics Clears Second Senate Committee (Marijuana Moment)

  • Drug-testing to be made permanent at music festivals (Newshub)

  • Oregon Legislature Adds Changes to Drug Decriminalization Law (Truffle Report)

  • COVID-19 and Psychedelic Group Work: It’s Still Too Soon (Psychedelics Today)

  • Washington State’s Drug Policies: Weighing Methods to Decriminalize Possession (Truffle Report)

  • Plant Medicine Coalition Launches Grants For Community Healing Hubs in D.C. (Truffle Report)

  • Ex Gov. Perry Backs Texas Psychedelics Study Bill (Truffle Report)

  • UCSF Launches Translational Psychedelic Research (TrPR) Program (Lucid News)

  • YouTube Loosens Restrictions, Expands Monetization for Drug Content (Truffle Report)

  • Fireside Project: The 21st Century’s First Psychedelic Peer Support Hotline (Lucid News)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - March 2021

This Month in Psychedelics.png

March was yet another busy month in the world of psychedelics. There was plenty of news involving drug policy, scientific research, the emerging psychedelic industry, and more. So if you’re looking to learn more about what happened this month in psychedelics then you’re in the right place!

Here is a slimmed-down video recap version that is available for those who prefer an easier-to-digest option:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Drug Policy

New Laws

Kicking things off, two new decriminalization laws took effect in the United States this month.

Washington D.C. decriminalized natural psychedelics like ayahuasca and psilocybin mushrooms and the capital city isn’t stopping there. The Plant Medicine Coalition is pushing the District Council to enact more legislation that would provide worker and child protections related to the use of plant- and fungi-based substances, among other initiatives that the group is working on.

Baltimore did something a bit surprising by decriminalizing all drugs as well as prostitution and several other low-level offenses. This move is part of an overall experiment known as The Covid Criminal Justice Policies, and it’s a unique approach to crime that was developed with public health authorities and inspired by the global pandemic. Instead of prosecuting people arrested for minor crimes, the program looks at them as public health issues and partners with organizations in the community to help find solutions rather than punish offenders.

Wins

In last month’s recap I reported that both Virginia’s House and Senate voted to legalize cannabis, but what I didn’t realize at the time was that each one of them approved a separate bill. Now Virginia’s House and Senate have both approved the same bill, which is currently on Governor Ralph Northam’s desk awaiting a signature that would make cannabis legal in the state by 2024.

However, Northam has thrown around the idea of moving up the legalization date to this July 1st and the leaders of Virginia’s House have expressed their support for this idea, so it’s possible that weed will be legal in the Old Dominion this summer.

Cannabis reform bills made advances in several other states as well: Hawaii, Wyoming, New York, Connecticut, and Illinois. And south of the border, Mexico’s lawmakers advanced a bill to legalize recreational cannabis, bringing the country one step closer to becoming one of the world’s largest marijuana markets.

Losses

Not all drug policy reform efforts were successful, however. Mississippi’s House killed the state’s medical marijuana bill, although the Senate hasn’t given up yet and is attempting a last-ditch effort to revive the bill. And Maryland’s cannabis legalization effort officially threw in the towel, so residents of the Old Line State will need to wait for either a future federal- or state-level initiative to enjoy legal marijuana from the comfort of their own homes.

New Bills and Initiatives

And there’s plenty drug policy news on the horizon as well—a New York lawmaker filed a bill to decriminalize psilocybin mushrooms in the state, lawmakers in Vermont and Rhode Island proposed decriminalizing all drugs, and activists in Michigan launched a campaign to decriminalize natural psychedelics.

Psychedelic Industry

Following on the heels of last month’s news that COMPASS Pathways is attempting to patent basic, preexisting psychedelic therapy techniques like using soft furniture and holding hands, the debate about patenting various aspects involving psychedelics continued to rage on this month.

A few well-known investors and players in the psychedelic industry had something to say about patents, including Rick Doblin, Tim Ferriss, Christian Angermayer, and David Bronner. At the heart of the matter is the fact that COMPASS Pathways has submitted patent applications for so many things involving psilocybin that Psymposia put together an astounding article detailing them that’s definitely worth checking out.

This is an important area to keep an eye on because it will impact all sorts of things, including who will be able to legally access and use psychedelics and which companies will be able to turn a profit in the emerging psychedelic industry.

Psychedelic Research

Researchers at Imperial College London published results from a groundbreaking placebo-controlled LSD microdosing trial. The study found that while participants who microdosed with active LSD ended up experiencing beneficial psychological effects, the placebos also engendered the same result. In fact, there was no statistical significance between an LSD microdose and a placebo pill.

This could mean that the benefits of microdosing come down to the placebo effect rather than an actual effect, but this study is by no means a definitive confirmation of that hypothesis. The study’s limitations include a relatively small sample size of 191 volunteers and a unique (and potentially flawed) self-blinding protocol.

More microdosing research will need to be conducted before we have a solid idea about its efficacy, but until then I’m sure microdosers will keep microdosing and getting benefits out of their practice regardless of whether those benefits come down to the psychedelic substance itself or the placebo effect.

In another study, researchers analyzed data from more than 171,000 adults who responded to the National Survey on Drug Use and Health between 2015 and 2018 and found that the use of psychedelics is associated with better physical health.

Roughly 14% of the sample reported using a classical psychedelic like LSD, mescaline, psilocybin, or DMT at least one time, and after controlling for a number of variables the results showed that those who reported ever using psychedelics tended to have better health than people who had never used a psychedelic before. Psychedelic users also had significantly lower odds of being overweight or obese.

It’s important with a study like this to remember that correlation doesn’t equal causation, but it’s interesting to know that a study with such a large sample size and variable controls found physical health to be significantly better among psychedelic users than the psychedelically-naïve.

Miscellaneous

Although many people in the psychedelic and wider drug-using communities were hopeful about President Joe Biden and Vice President Kamala Harris’ approach to drug policy, so far things haven’t exactly gotten off on the right foot. In addition to the fact that the drug war is still going strong, several White House staffers were asked to resign, were suspended, or are being required to work remotely after revealing past cannabis use during their background checks, even if that use occurred in states where marijuana has been legalized. This isn’t too surprising though, considering that cannabis is still illegal at the federal level, which can make it challenging for government employees to get federal security clearance.

However, what makes this extra frustrating is that several staffers had been previously told by transition officials that past cannabis use would be overlooked, only to be told later that they would need to resign. This flip-flopping is par for the course when it comes to politicians and politics in general, but it’s still aggravating to see Biden’s administration pull a bait-and-switch here.

Hopefully in the future they’ll be able to relax a bit and not exclude people on the basis of prior drug use. I know a natural remedy that might help them chill out but something tells me they won’t be interested…

Last up this month is a story about why PCP users almost exclusively live in America. The linked VICE article explores the curious reasons behind why the drug never went global like crack cocaine or LSD.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Month in Psychedelics - January 2021

This Month in Psychedelics.png

We’re only one month into the new year but it’s safe to say that January is already the craziest month of 2021. And judging from last year, it’s pretty likely that this trend will continue well on into the rest of the year, so we need to properly set our expectations, buckle our seat belts, and enjoy the ride as much as we possibly can.

In this month’s recap we’ll be taking a look at the biggest psychedelic news stories that took place, including a cautionary tale about magic mushrooms, the psychedelic guru who stormed the U.S. Capitol, a city in Massachusetts that decriminalized natural psychedelics, a new psilocybin church in Salt Lake City, and much more.

Here is a slimmed-down video recap version that is available for those who prefer an easier-to-digest option:

There’s a lot to get through this month, so without further ado, let’s jump into the news:

Magic Mushrooms Grew in a Man’s Veins After He Injected Psilocybin Mushroom Tea

If you’ve ever thought about injecting magic mushrooms into your veins, you might want to give up on that idea after finding out what happened to a man who did just that.

A new case report published this month shared a frightening story about an opioid user who attempted to self-medicate his depression and drug dependence by injecting homemade mushroom tea into his body. The experiment caused a life-threatening infection that prompted psilocybin to grow inside of him and resulted in a month-long hospital stay.

Fortunately he survived, but this should serve as a cautionary tale for others to avoid this route of administration for magic mushrooms. After all, simply eating them or drinking mushroom tea has already stood the test of time for psychonauts all around the world.

A Self-Proclaimed Psychedelic Guru Known as the “QAnon Shaman” Stormed the Capitol

The United States underwent a traumatic event on January 6th when a diverse group of insurrectionists stormed the Capitol in an attempt to prevent the certification of the 2020 presidential election, resulting in five deaths and the evacuation of Congress.

Among them was a self-appointed psychedelic guru who goes by the name “QAnon Shaman.”

Advocating for psychedelic shamanism to heal the world while also taking part in a violent act, Jake Angeli is a living example of the wide spectrum of psychedelic users that includes not only left-leaning hippies but also alt-right conspiracy theorists.

Angeli has a long strange history in the psychedelic community, offering courses and consultations on woo-woo topics like ascension and ESP, protesting against the Black Lives Matter movement, and supporting conspiracy theories like the idea that COVID-19 is a hoax and the far right QAnon hogwash.

If you’re interested in learning more about the mysterious symbols tattooed on Angeli’s chest, be sure to check out Psymposia’s guide explaining what each one means in context.

Somerville, Massachusetts Decriminalized Natural Psychedelics

Somerville, Massachusetts hopped on the psychedelic policy reform bandwagon by decriminalizing natural psychedelics like psilocybin mushrooms, ayahuasca, and iboga.

A coalition including Bay Staters for Natural Medicine and Decriminalize Nature Massachusetts presented the legislation to the Somerville City Council which unanimously voted 9-0 to approve the decriminalization bill.

The resolution will prompt the city’s legal department to work with community activists to finalize an ordinance and asks the local police and district attorney to deprioritize the enforcement of use and possession charges.

A Former Mormon Politician Started A Psilocybin Church Called “The Divine Assembly”

A former Latter-day Saint politician with some impressive cajones formed a psilocybin church in Salt Lake City, Utah. Dubbed “The Divine Assembly”, the church serves magic mushrooms as a sacrament that enables its members to commune with the divine.

Since The Divine Assembly provides an illicit substance to its congregation, the church’s faith may eventually be tested in court to see if its members have a “sincerely-held religious belief” as required by the Religious Freedom Restoration Act if they want to continue using psychedelics as a religious group.

Until then, the church plans to continue serving its psilocybin sacrament without the federal government’s blessing.

Will Marijuana Be Legalized This Year?

Now that there is a Democratic majority in the U.S. Senate, stoners all over the country are asking whether we’ll see weed get legalized this year. Combined with Joe Biden’s recent presidential victory, the new Congress means that federal cannabis reform might finally be a possibility within the next two years.

When it comes to statewide reforms, several states have the potential to legalize cannabis this year: Connecticut, Delaware, Maryland, Minnesota, New Mexico, New York, Pennsylvania, Rhode Island, Virginia, and Wisconsin. And to sweeten the pot, Alabama, Kentucky, and South Carolina might legalize medical marijuana.

It’s too early to tell how many of these reform efforts will succeed, but one thing’s for sure—it’s shaping up to be a progressive year for cannabis policy.

New Psychedelic Reform Group Sets Its Sights on Federal Decriminalization

A new psychedelic reform group known as the Plant Medicine Coalition has set its sights on lobbying Congress to federally decriminalize natural psychedelic medicines. The group is a women-led, non-profit, grassroots advocacy organization, showing that women are leading the charge in this area of drug policy reform.

The Plant Medicine Coalition’s leader also founded the campaign that got psychedelic decriminalization passed in Washington, D.C. during last November’s election, so they are certainly experienced enough to make significant waves toward decriminalizing natural psychedelics across the United States.

Florida and Hawaii Could Legalize Psilocybin Therapy

A lawmaker in Florida is planning to introduce a psilocybin therapy legalization bill that could put the state on the map as the first in the Southeast—and the first red state—to approve a non-cannabis-related psychedelic reform bill. The legislation is modeled after the recently-approved voter initiative that passed in Oregon during last November’s election, so it would not allow recreational users to possess or consume magic mushrooms but would instead set up a legal framework for psilocybin therapy.

Hawaii's Senate is one step ahead of Florida because it already filed a new bill that would establish designated treatment centers and deschedule the psychedelic from the state's list of Schedule I controlled substances.

Meanwhile, recreational users in Colorado might have the option to trip on shrooms from the comfort of their own home in the near future. Kevin Matthews, who led Decriminalize Denver’s successful 2019 campaign to decriminalize psilocybin in the city, is beginning work on an effort to decriminalize magic mushrooms all across Colorado.

The Third (and Likely Final) Season of Hamilton's Pharmacopeia Is Out

Fans of the show Hamilton’s Pharmacopeia, where host Hamilton Morris explores the history, chemistry, and social impact of psychoactive substances, have a reason to rejoice because the third season of the popular docuseries is out now.

The new season’s reception has been favorable, with the first four episodes that have been released so far focusing on 5-MeO-DMT, methamphetamine, Xenon, and the extraordinary alkaloids of Africa. This is likely to be the show’s final season, so be sure to soak it all up while you can.

Mount Sinai Launched a New Center for Psychedelic Research

There still aren’t a whole lot of centers that are dedicated to researching psychedelics in the world, but a new one opened up this month. The Icahn School of Medicine at Mount Sinai launched a new center that is going to explore using psychedelics for PTSD, depression, anxiety, and other stress-related conditions.

And Mount Sinai isn’t wasting any time—they’ve already published a study that found that repeated IV injections of ketamine significantly reduced the severity of symptoms in people with chronic PTSD.

Hopefully we’ll eventually get to a point where there are such a plethora of psychedelic research centers that it’s not big news when a new one opens, but until that happens I’m going to keep highlighting new ones in these updates.

Additional Top Stories

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 1.29.21

ThisWeekinPsychedelics.png

Cannabis

  • Arizona: Adult Use Marijuana Sales Begin (NORML)

  • 2 Years After Legalizing Cannabis, Has Canada Kept Its Promises? (The New York Times)

  • Alabama Could Legalize Medical Marijuana Under Bill Filed By Republican Senator (Marijuana Moment)

  • CBD Destroys Antibiotic-Resistant Bacteria Such as Gonorrhea, Study Finds (VICE)

  • Chuck Schumer Lists Marijuana As A Priority In First Post-Election Cannabis Comments (Marijuana Moment)

  • Anti-Marijuana Lawmaker Files Legalization Bill In North Dakota To Avoid Activist Ballot Measure (Marijuana Moment)

  • Areas With More Marijuana Dispensaries Have Fewer Opioid Deaths, New Study Finds (Marijuana Moment)

  • Opioid Prescriptions Decline in Canada Following Enactment of Adult-Use Marijuana Legalization (NORML)

  • Transition From Trump To Biden Impacts Federal Hemp And CBD Rules (Marijuana Moment)

  • Michigan testing labs sound warning about contaminated cannabis (Marijuana Business Daily)

  • Bill To Allow Medical Marijuana Use At Hotels And Airbnbs Filed In Missouri (Marijuana Moment)

LSD

  • LSD breakthrough could enable treatment for autism and social anxiety, research finds (Sky News)

Magic Mushrooms

  • Hawaii Could Legalize Psychedelic Mushroom Therapy Under New Senate Bill (Marijuana Moment)

  • Kevin Matthews Wants to Decriminalize Mushrooms Across Colorado (Westword)

  • Port Townsend woman seeks decriminalization of ‘magic’ mushrooms (Peninsula Daily News)

  • UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition (Psilocybin Alpha)

  • Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility (Psilocybin Alpha)

  • Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland (Psilocybin Alpha)

  • MagicMed Files For Psilocybin Derived Patents (Green Market Report)

  • Is America Ready For Psilocybin Mushroom Retreats? (Benzinga)

MDMA

  • Will Australia legalise ecstasy and magic mushrooms to treat mental illness? Here’s why it’s still too soon (The Conversation)

DMT

Ayahuasca

  • Ayahuasca, Severe Illnesses, and the Mystery of Death (Chacruna)

  • Woman, 29, killed herself after ‘suffering psychosis from taking hallucinogenic yoga drugs on spiritual retreat’ (The Sun)

  • Ayahuasca’s Role in the Entourage Effect and Depression (Psychedelic Science Review)

  • An Ayahuasca Retreat Brings Powerful Changes (Healing Maps)

Peyote

  • Let’s Talk About Hikuri: A Peyote Conservation Project by the Wixárika (Chacruna)

Iboga

  • How the psychedelic Ibogaine helped a retired Vancouver firefighter treat his depression (The GrowthOp)

Novel Psychoactive Substances

  • BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies (Psilocybin Alpha)

Ketamine

  • Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression (Psilocybin Alpha)

  • Ketamine to treat depression and addiction at UK’s first medical psychedelic psychotherapy clinic (iNews)

  • Users of ketamine at significantly higher risk of suicide: study (Focus Taiwan)

  • A Wall Street banker who made millions in the dot com boom dropped it all to become a 'psychedelics concierge' to the stars. Now he wants everyone to have access to ketamine. (Insider)

  • How to Know if Ketamine Therapy Is Right for You (Santa Clarita Magazine)

DXM

  • Low-dose dextromethorphan for the treatment of fibromyalgia pain: results from a longitudinal, single-blind, placebo-controlled pilot trial (MD Linx)

Miscellaneous

  • New Psychedelics Reform Group Sets Sights On Congress As Movement Builds (Marijuana Moment)

  • Atlanta: Mayor Takes Executive Action Abolishing Pre-Employment Drug Screens for Many Public Employees (NORML)

  • The Latest on Psychedelics for Treating Dementia (Psychedelic Science Review)

  • The world's first psychedelic ETF debuts (Yahoo! Finance)

  • Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US (Psilocybin Alpha)

  • The Cop Who Busted the Beatles Now Wants to Legalise All Drugs (VICE)

  • When The Giants Of Indian Classical Music Collided With Psychedelic San Francisco (NPR)

  • Mydecine Innovations Group Files Application to list to the NASDAQ (Psilocybin Alpha)

  • Biden Ending Federal Contracts With Private Prisons; Private ICE Detention Continues (Filter)

  • 5 Athletes Who Healed With Psychedelic Therapy (Benzinga)

  • “A ‘Dose’ of Radical Christianity”: Psychedelic Therapy with Dr. Florence Nichols (Chacruna)

  • atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents (Psilocybin Alpha)

  • Ohio Students Launch Harm Reduction and “Bad Batch” Alerts App (Filter)

  • Taking Psychedelics When You’re Not Feeling Good (Maps of the Mind)

  • In Brazil, Bolsonaro Continues to Pump Blood to the War on Drugs (TalkingDrugs)

  • Inside The Underground World Of Online Psychedelic Support Groups (Benzinga)

  • MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category (Psilocybin Alpha)

  • How to Start a Career in the Field of Psychedelic Integration (The Third Wave)

  • Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market (Psilocybin Alpha)

  • Mental Health Issues That Don't Mix Well With Psychedelics (Healing Maps)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

New Psychedelic Reform Group Sets Its Sights on Federal Decrim

Kyle Jaeger, writing for Marijuana Moment:

The psychedelics reform movement has seen a wave of successes at the state and local level over the past couple years, but a newly formed group says the timing is right to take their activism to the next stage: Congress.

The Plant Medicine Coalition (PMC)—founded by the head of the Washington, D.C. campaign that got psychedelics decriminalization passed locally in November’s election—is a national organization that hopes to build upon what’s already been accomplished and bring the issue to Capitol Hill, in part by pushing lawmakers to approve federal funding for research into the therapeutic potential of substances like psilocybin mushrooms and ayahuasca.

They will also work to ensure the effective implementation of D.C.’s city-level policy change while supporting other local activists as they push to change laws governing natural or synthetic psychedelics.

An attempt to decriminalize psychedelics at the federal level—bravo. And what makes this even better is that the Plant Medicine Coalition is a women-led, non-profit, grassroots advocacy organization. Here’s hoping they succeed; it certainly won’t be easy.

The group’s Twitter account is brand-new but it’s worth a follow if you want to keep up-to-date with their progress.